In the present study, rebiopsy revealed that transformation to LCNEC was the mechanism underlying the resistance to EGFR TKI and subsequently led to effective treatment of our patient (Fig. 3). This evidence concerns the gene EGFR and large cell neuroendocrine carcinoma.